黑龙江国中水务股份有限公司 2024 年度独立董事述职报告 作为黑龙江国中水务股份有限公司（以下简称"公司"）的独立董事，2024年度，本人严格按照《公 司法》、《证券法》、《上市公司独立董事管理办法》等法律、法规、规范性文件要求，以及《公司章程》， 《独立董事工作制度》等制度规定，本着对全体股东负责的态度，谨慎、认真、勤勉地履行了独立董事的 职责，积极出席公司召开的相关会议，认真审议董事会各项议案，并对相关议案发表了独立意见，充分发 挥了独立董事的独立作用，切实维护了公司和股东尤其是中小股东的利益。对董事会的科学决策、规范运 作以及公司发展都起到了积极作用。 现将 2024 年度个人履职情况汇报如下： 一、独立董事的基本情况 （一）独立董事人员情况 公司董事会目前设有三名独立董事：贺建芬女士、陈相奉先生、王建伟先生。人数占董事会人数三分 之一以上，独立董事任职上市公司家数均不超过三家，符合相关法律法规的要求。公司董事会审计委员会、 提名委员会、薪酬与考核委员会的主任委员均由独立董事担任，且独立董事均占多数。 （二）个人工作履历、专业背景以及独立性情况说明 本人贺建芬，1963年12月出生，1986年毕业于华 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 51,934,115.43, representing a 21.13% increase compared to CNY 42,874,594.13 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 1,023,073.82, a decrease of 152.00% from a profit of CNY 1,967,267.58 in the previous year[4] - The basic earnings per share decreased by 150.00%, resulting in a loss of CNY 0.0006 per share compared to a profit of CNY 0.0012 per share last year[5] - The company incurred increased costs related to the termination of employee contracts, impacting net profit significantly[7] - Total operating revenue for Q1 2025 reached ¥51,934,115.43, an increase of 21.5% compared to ¥42,874,594.13 in Q1 2024[17] - Net profit for Q1 2025 was a loss of ¥2,922,359.11, compared to a profit of ¥1,065,697.78 in Q1 2024[18] - Comprehensive income for Q1 2025 was a loss of ¥3,209,356.33, compared to a loss of ¥11,984,800.03 in Q1 2024[19] - Basic and diluted earnings per share for Q1 2025 were both -¥0.0006, down from ¥0.0012 in Q1 2024[19] Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,446,490,236.94, down 4.28% from CNY 3,600,734,727.21 at the end of the previous year[5] - As of March 31, 2025, the company's total assets amounted to RMB 3,446,490,236.94, a decrease from RMB 3,600,734,727.21 as of December 31, 2024, reflecting a decline of approximately 4.26%[13][15] - The company's current assets totaled RMB 1,160,019,611.79, down from RMB 1,314,010,065.19, indicating a decrease of about 11.69%[14] - The company's total liabilities decreased to RMB 229,538,442.68 from RMB 380,573,576.62, a reduction of about 39.5%[15] - The total equity remained stable at RMB 3,216,951,794.26, with no change reported from the previous period[15] - The company reported a significant reduction in held-for-sale assets, decreasing from RMB 577,324,073.23 to RMB 322,403,589.64, a decline of approximately 44.24%[14] Cash Flow - The cash flow from operating activities showed a net outflow of CNY 47,245,901.85, compared to an outflow of CNY 27,085,493.06 in the same period last year[4] - Cash inflows from operating activities in Q1 2025 totaled ¥33,161,122.51, compared to ¥31,862,091.50 in Q1 2024, indicating a growth of 4.1%[22] - The net cash flow from operating activities was -$47.25 million, compared to -$27.09 million in the previous period, indicating a decline of approximately 74.5%[23] - Total cash outflow from operating activities was $80.41 million, compared to $58.95 million, marking an increase of approximately 36.4%[23] - Cash inflow from investment activities totaled $245.09 million, up from $198.96 million, representing an increase of about 23%[23] - The net cash flow from investment activities was $152.89 million, a significant improvement from -$25.42 million in the prior period[23] - Cash outflow for financing activities was $9.12 million, compared to $5.55 million previously, reflecting an increase of approximately 64.5%[23] - The ending balance of cash and cash equivalents was $267.06 million, down from $318.14 million, a decrease of about 16%[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 121,912, with no preferred shareholders with restored voting rights[9] - The company has no significant changes in the number of shareholders or their shareholding percentages during the reporting period[11] - The company did not engage in any financing or securities lending activities during the reporting period[11] Research and Development - The company reported a significant increase in R&D expenses, totaling ¥1,711,794.32 in Q1 2025, compared to ¥894,499.66 in Q1 2024, reflecting a growth of 91.1%[17] Other Financial Metrics - Non-recurring gains and losses amounted to CNY 1,228,319.82, primarily due to asset disposal gains and government subsidies[6] - The weighted average return on net assets decreased by 0.092 percentage points, reflecting a decline in profitability[5] - The company experienced a decrease in investment income, reporting ¥22,334,308.55 in Q1 2025, compared to ¥20,222,477.48 in Q1 2024[17] - The company’s minority shareholders' equity decreased to ¥12,989,134.55 in Q1 2025 from ¥14,888,419.84 in Q1 2024[16] - Cash received from the disposal of subsidiaries and other business units was $9.91 million, up from $5 million, indicating an increase of 98.2%[23] - Cash paid for investments was $86.46 million, significantly lower than $190 million in the previous period, a decrease of about 54.5%[23] - The cash flow impact from foreign exchange fluctuations was -$55,760.69, contrasting with a positive impact of $39,713.77 previously[23] - The total cash inflow from financing activities was $1.3 million, unchanged from the previous period[23]

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 43.58 million for the fiscal year 2024, with an ending undistributed profit of RMB -343.83 million[6]. - The parent company reported a net profit of RMB 176.77 million, with a legal surplus reserve of RMB 17.68 million deducted, resulting in a distributable profit of RMB 61.48 million at the end of 2024[6]. - The company plans not to distribute profits or increase capital reserves for the fiscal year 2024[6]. - The company's operating revenue for 2024 was CNY 179,155,656.23, a decrease of 20.73% compared to CNY 226,015,499.45 in 2023[22]. - The net profit attributable to shareholders for 2024 was CNY 43,579,164.52, an increase of 43.58% from CNY 30,350,814.21 in 2023[22]. - The basic earnings per share for 2024 was CNY 0.0270, reflecting a 43.62% increase compared to CNY 0.0188 in 2023[23]. - The total assets at the end of 2024 were CNY 3,600,734,727.21, a decrease of 0.94% from CNY 3,634,875,627.10 at the end of 2023[22]. - The cash flow from operating activities for 2024 was negative CNY 4,351,744.60, a decline of 108.28% compared to CNY 52,581,260.24 in 2023[22]. - The company reported a net profit of CNY 34,581,224.76 in the fourth quarter of 2024, significantly higher than the previous quarters[24]. - Non-recurring gains and losses for 2024 totaled CNY 35,122,163.53, compared to CNY 14,227,906.93 in 2023[27]. Operational Efficiency - The company plans to continue focusing on government subsidies and financial asset management to improve profitability in the future[26]. - The company aims to reduce average energy consumption in sewage treatment plants by over 5% and increase the reuse rate of reclaimed water to over 25% by 2025[33]. - The company operates seven sewage treatment project companies under a BOT model, ensuring compliance with sewage discharge standards[31]. - The company is actively working on project management and operational efficiency to support sustainable development strategies[41]. - The company has established a management control system in place for subsidiaries, ensuring stable operations across all fully-owned subsidiaries[115]. Market and Strategic Developments - The urban sewage treatment market is expected to exceed 600 billion yuan in 2024, driven by government policies and increased demand for industrial wastewater treatment[33]. - The company plans to optimize and upgrade existing businesses and assets while exploring new fields such as green health food and new environmental materials by 2025[32]. - The company has made strategic investments in green health food and new environmental materials, including indirect investment in Beijing Huiyuan and equity investment in Lianggu Ecology[32]. - The company is focused on expanding its health technology development through its subsidiary, Shanghai Pengdu Health Technology Development Co., Ltd.[85]. - The company is exploring partnerships with tech firms to enhance its service offerings and improve customer satisfaction metrics[91]. Governance and Compliance - The company has established a comprehensive governance structure, including a board of directors with 7 members and various specialized committees to ensure effective decision-making and oversight[77]. - The company strictly adheres to information disclosure regulations, ensuring transparency and fairness for all shareholders[78]. - There were no significant differences in corporate governance compared to regulatory requirements[78]. - The company has established measures to maintain independence in assets, personnel, and operations[78]. - The company has faced regulatory warnings and penalties, highlighting potential compliance issues that may affect its operations[96]. Financial Management and Investments - The company has a total of RMB 460,000,000.00 in structured deposits, with a fair value change of RMB 370,759,800.00 during the period[66]. - The company has invested CNY 140 million in bank wealth management products, with an outstanding balance of CNY 90 million[157]. - The company has also invested CNY 100 million in private equity funds, with an outstanding balance of CNY 45.1 million[157]. - The total amount of expected returns from entrusted financial management is RMB 102,739.73 and RMB 109,589.04 from two separate bank financial products, both with an annualized yield of 2.50%[158]. - The company has reported a loss of RMB 7,361,600.00 from a non-guaranteed fund management product[160]. Environmental Compliance - The company has maintained compliance with environmental standards, with all wastewater discharge meeting regulatory limits throughout the year[118]. - The company has established emergency response plans for environmental incidents across its sewage treatment projects[124]. - The company has implemented automatic online monitoring for key pollutants, with monitoring frequencies ranging from hourly to quarterly depending on the project[125][126]. - The company faced administrative penalties for exceeding daily average COD and total nitrogen limits, with fines of CNY 380,000 and CNY 400,000 respectively[128][129]. - No carbon reduction measures were reported during the reporting period, with zero tons of CO2 equivalent emissions reduced[129]. Shareholder and Board Activities - The company completed the board of directors' re-election during the reporting period[78]. - All proposals presented at the shareholders' meeting were approved[80]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to CNY 3,072,534.2[94]. - Changes in the board included the resignation of Yan Dongming and Wang Bing due to term expiration, and the election of new directors and supervisors[95]. - The company has a total of 3,072,534.2 shares outstanding as of the latest report[85]. Legal and Arbitration Matters - The company is involved in an arbitration case regarding unpaid wastewater treatment fees amounting to approximately 116.59 million RMB, with a ruling in favor of the company for 46.67 million RMB[139]. - The company has faced difficulties in obtaining necessary materials for the merger, leading to a breach of contract claim against the respondents[141]. - The company is actively pursuing legal remedies to recover its investments and ensure compliance with contractual obligations[141]. - There are no significant litigation or arbitration matters reported for the current year, indicating a stable legal environment for the company[138]. - The company has not faced any delisting risks or bankruptcy restructuring issues, reflecting a stable financial position[138].

黑龙江国中水务股份有限公司 募集资金存放与使用情况鉴证报告 深旭泰核字[2025]019 号 深圳旭泰会计师事务所（普通合伙） Xutai Certified Public Accountants (General Partnership) 0755-27709801 (电话)TEL: (地址)ADDRESS： 深圳市福田区滨河大道 9003 号湖北大厦 29 南 B 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://gromaf -师行业经 报告编码:粤25YG4 黑龙江国中水务股份有限公司 募集资金存放与使用情况鉴证报告 (2024 年度） | | 目 录 | 页 次 | | --- | --- | --- | | | 募集资金存放与使用情况鉴证报告 | 1-2 | | | 黑龙江国中水务股份有限公司 2024年度募集资金存放 | 1-10 | | | 与实际使用情况的专项报告 | | 黑龙江国中水务股份有限公司 募集资金存放与使用情况鉴证报告 深旭泰核字[2025]019 号 黑龙江国中水务股份有限公司全体股东: 我们审核了后附的黑龙江国中水务股份有限公司(以下简称国中水务公司) ...

黑龙江国中水务股份有限公司 非经常性损益专项核查意见 深旭泰核字[2025]020 号 深圳旭泰会计师事务所（普通合伙） Xutai Certified Public Accountants (General Partnership) (电话)TEL: 0755-27709801 (地址)ADDRESS: 深圳市福田区滨河大道 9003 号湖北大厦 29 南 B 黑龙江国中水务股份有限公司全体股东: ， 黑龙江国中水务股份有限公司 非经常性损益专项核查意见 (2024 年 1 月 1 日至 2024 年 12 月 31 日) | | 目 | 求 | 页 TR | | --- | --- | --- | --- | | | 非经常性损益专项核查意见 | | 1-2 | | 1 Í | 非经常性损益明细表 | | 1-2 | | 111 | 非经常性损益明细表附注 | | 기 | 黑龙江国中水务股份有限公司 非经常性损益专项核查意见 深旭泰核字[2025]020 号 我们接受委托,对黑龙江国中水务股份有限公司(以下简称国中水务公司)2024 年度财务报表进行审计,并出具了深旭泰财审字[2025]360 号审计报告 ...

黑龙江国中水务股份有限公司 2024 年度募集资金存放与使用情况的专项报告 根据《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监管要求》 （证监会公告[2022]）15 号）、《上海证券交易所上市公司监管指引第 1 号—规 范运作》等相关法律、法规和规范性文件以及公司现行管理制度的相关规定，现 将黑龙江国中水务股份有限公司（以下简称公司）截至 2024 年 12 月 31 日的募 集资金存放与实际使用情况报告如下。 一、募集资金基本情况 （一）募集资金金额及到账情况 经中国证券监督管理委员会证监许可[2016]3220 号文核准，公司获准非公 开发行人民币普通股（A 股）198,310,900 股，发行价格为 4.80 元/股。本次发 行募集资金总额为人民币 951,892,320.00 元，扣除发行费用 29,550,310.90 元， 募集资金净额为人民币 922,342,009.10 元。上述募集资金于 2017 年 2 月 24 日 存入公司指定的募集资金专用账户。中准会计师事务所（特殊普通合伙）对募集 资金到位情况进行了验证，并出具了中准验字[2017]1017 号《非公开发行人民 币普 ...

重要内容提示： 关于续聘会计师事务所的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 证券代码：600187 证券简称：国中水务 编号：临 2025-018 黑龙江国中水务股份有限公司 拟聘任的会计师事务所名称：深圳旭泰会计师事务所（普通合伙）（以下简称"旭泰所"） 黑龙江国中水务股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开第九届董事会第十次会议、 第九届监事会第七次会议审议通过《关于续聘 2025 年财务审计机构的议案》、《关于续聘 2025 年内控审计 机构的议案》，同意公司继续聘任深圳旭泰会计师事务所（普通合伙）为公司 2025 年财务及内控审计机构。 现将具体情况公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 截至 2024 年度末合伙人数量：6 截至 2024 年度末注册会计师人数：64 截至 2024 年度末签署过证券服务业务审计报告的注册会计师人数：6 （7）业务信息 2024 年度收入总额（经审计）：2,200.52 万元 2024 年度审计业务收入（经审计）： ...

证券代码：600187 证券简称：国中水务 编号：临 2025-017 黑龙江国中水务股份有限公司 关于使用闲置自有资金进行委托理财的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、委托理财情况 1、委托理财目的 为提高公司资金使用效率，合理利用闲置自有资金，增加资金收益，在确保资金安全性、流动性且不 影响公司正常经营的基础上，公司及下属子公司拟使用闲置自有资金进行委托理财，用于购买银行及其他 金融机构的理财产品。 2、投资额度及期限 拟使用最高额度不超过人民币 6 亿元的闲置自有资金进行现金管理，该额度可滚动使用。 3、投资品种 主要用于投资合法金融机构发行的风险可控、中等风险及以下、流动性好的理财产品。不用于其他证 券投资，不购买股票及其衍生品、无担保债券为投资标的的产品。 4、履行的审批程序 本次使用闲置自有资金进行委托理财的议案已经公司第九届董事会第十次会议、第九届监事会第七次 会议审议通过。本次公司使用闲置自有资金进行委托理财尚需提交公司 2024 年度股东大会审议。 5、实施方式 授权 ...

黑龙江国中水务股份有限公司 董事会审计委员会对会计师事务所 2024 年度履行监督职责情况报告 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司治理准则》、《国有企业、 上市公司选聘会计师事务所管理办法》、《上海证券交易所上市公司自律监管指引第 1 号—规范运作》等 相关法律法规和《公司章程》、《董事会审计委员会实施细则》的有关规定，公司董事会审计委员会本着 勤勉尽责的原则，恪尽职守，认真履职。现将董事会审计委员会对会计师事务所 2024 年度履行监督职责情 况汇报如下： 一、2024 年度会计师事务所的履职情况评估报告 （一）聘任会计师事务所程序及会计师事务所基本情况 公司于 2024 年 4 月 28 日及 2024 年 6 月 27 日召开第八届董事会审计委员会第十五次会议、第八届董 事会第二十九次会议、2023 年年度股东大会，审议通过了《关于续聘中准会计师事务所为公司 2023 年内控 审计机构的议案》及《关于续聘中准会计师事务所为公司 2023 年财务审计机构的议案》，同意续聘中准为 公司 2024 年度内控审计机构和财务审计机构。 2025 年 2-3 月，鉴于中准所受到中国证 ...

申万宏源证券承销保荐有限责任公司 关于黑龙江国中水务股份有限公司 2024 年度 募集资金存放与使用情况的专项核查报告 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或"保 荐人"）作为黑龙江国中水务股份有限公司（以下简称"国中水务"或"公司"） 非公开发行股票持续督导工作的保荐人，根据《证券发行上市保荐业务管理办法》、 《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监管要求》《上海 证券交易所上市公司自律监管指引第 1 号——规范运作》《上海证券交易所上市 公司自律监管指引第 11 号——持续督导》等有关规定，对国中水务 2024 年度募 集资金存放与使用情况进行了核查，具体情况如下： 截至 2024 年 12 月 31 日，公司及作为募投项目实施主体的子公司募集资金 累计使用及结余情况如下： 一、募集资金基本情况 1、募集资金金额及到账情况 经中国证券监督管理委员会证监许可[2016]3220 号文核准，公司获准非公开 发行人民币普通股（A 股）198,310,900 股，发行价格为 4.80 元/股。本次发行募 集资金总额为人民币 951,892,320.00 元，扣除发行费 ...